Nucleic acid amplification (NAA) is one of the most commonly performed molecular biology techniques and is a necessary precursor to a range of methods from gene cloning and site-directed mutagenesis to the quantitative analysis of gene expression. As life science suppliers continue to improve products and services in the nucleic acid amplification market, nucleic acid amplification kits and reagents…

Next generation sequencing (NGS) library preparation is a crucial step in the NGS workflow. Product evolution in this area has been swift – from original laborious, multi-day protocols requiring reagents from several suppliers, to complete kits optimized for low input, challenging sample types and automation-ready formats. Powerful and continually evolving methods are currently employed by scientists in basic and…

To keep the global research community and research product suppliers informed on the continuing impact of the COVID-19 pandemic on research efforts Percepta fielded the first COVID-19 Impact survey on April 3, 2020.  This survey was re-fielded, with the addition of several questions, on May 1, 2020 and once more on June 1, 2020.

CRISPR technology is a simple yet powerful tool for editing genomes. It allows researchers to easily alter DNA sequences and modify gene function. Its many potential applications include correcting genetic defects, treating and preventing the spread of diseases and improving crops. As life science suppliers continue to improve products and services the CRISPR gene/genome editing market, represents a significant…

The first version of this Pulse Report was published in early April 2020.  As the COVID-19 pandemic continues to take its toll on research programs across academia and pharma/biotech globally we are providing this updated complimentary report from Percepta has been provided to help you stay informed on the pandemic’s current impact on laboratory closures, funding, headcount, project changes,…

As the COVID-19 pandemic takes its toll on research programs
across academia and pharma/biotech we are in turn interested to better
understand the current research landscape and how we can best support it.

On April 3, 2020 we fielded a brief survey to the Percepta panel of life scientists. We received 1,015 completed surveys from around the globe.  Key findings from the…

Qiagen’s dominant position remains with leadership in fifteen of the eighteen nucleic acid purification segments surveyed

Carlsbad, Calif. – March
1, 2020 – Today Percepta
Associates released its 2020
DNA Purification, Series 1, Life Science Dashboard™ and 2020
RNA Purification, Series 1, Life Science Dashboard™ reports. These reports
update findings from Percepta’s previously published 2016 Nucleic Acid
Purification Dashboard.  2020 reports see
the addition of several new…

Carlsbad, Calif. – November 9, 2016 – Today Percepta Associates released its 2016 Quantitative Immunoassay, Series 3 Life Science Dashboard™ report which draws comparisons to key market indicator data reported in Percepta’s 2013 Series 2 Dashboard report.   This updated dashboard reveals increased usage of all immunoassay methods surveyed except for colorimetric ELISA, with the best growth opportunities in chemiluminescent…

October 7th 2016 –  Percepta Associates Inc. has been selected for the 2016 California Excellence Award for client services in market research among all its peers and competitors by the American Economic Institute (AEI).

Percepta Associates Inc. has consistently demonstrated a high regard for upholding business ethics and company values. This recognition by AEI marks a significant achievement as an emerging…

In a recent summary of the presumptive presidential nominees’ positions on issues related to science and the environment including GMO labeling, global climate change and fossil fuels, there was a clear dichotomy.  That is not likely to surprise many in an election year.  However, we were interested in seeing what actual scientists thought of these “Science and Environment” political issues.

Percepta polled…